PAQ Therapeutics is Drug Discovery in United States that focus on small-molecule degraders business. Founded in 2020. They cover business area such as operator, heath and cure disease, autophagy, small-molecule, autophagosome-tether compound technology, substrate, physician, serious disease, therapeutic option, patient.
2020
( 4 years old in 2024 )
Small-molecule Degraders
-
625 Mass Avenue
Office 02-146
Cambridge, MA 02139
United States
Private
operatorheath and cure diseaseautophagysmall-moleculeautophagosome-tether compound technologysubstratephysicianserious diseasetherapeutic optionpatient
* We use standard office opening hours in near PAQ Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
PAQ Therapeutics is Drug Discovery business from United States that founded in 2020 (4 years old in 2024), PAQ Therapeutics business is focusing on Small-molecule Degraders.
PAQ Therapeutics headquarter office and corporate office address is located in 625 Mass Avenue Office 02-146 Cambridge, MA 02139 United States.
PAQ Therapeutics was founded in United States.
In 2024, PAQ Therapeutics is currently focus on small-molecule degraders sector.
Above is snippet of Google Trends for "small-molecule degraders" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with PAQ Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
